

The NHC is one of the largest, most modern university medical centres in France.
By exemplifying the values of innovation, architecture and quality of space,
it will set the standard for the next generation of hospitals.
![]() © NHC |
![]() © NHC |
![]() © NHC |
The Institut Clinique de la Souris - ICS (Mouse Clinical Insitute - MCI) is a research infrastructure of excellence for translational research and functional genomics. It provides a comprehensive set of specialised services to academic and industrial users and is a major player in the European post-genomics era programs.The ICS combines the capacity of generating mutant mice on a large scale with a high-throughput and comprehensive phenotypic analysis of the animals. The Institute's phenotyping platforms are adapted for the study of genetically engineered mouse models and genetic reference populations but can also be used for preclinical studies including the validation of therapeutic targets as well as pharmacological and toxicological studies in the mouse.
Learn more
This independent tests laboratory, located in Strasbourg, allow the evaluation of prosthesis explants in the vascular field. This platform characterizes a big range of prosthesis explants in an independent way, in order to build an IT database. All the results are opened to Health Institutions, Professional societies and to the manufacturers of the concerned medical devices in order to improve technical innovations.
Analysis, Measurement & Optical spectroscopy (AMS), Institute of Chemistry of Strasbourg
The platform of optical spectroscopy is available to all scientists( regardless of their research team assignment). They provide access to equipment and expertise in:
- luminescence spectroscopy
- circular dichroism spectropolarimetry
- polarimetry
- CHN elemental analysis.
Learn more
© Institut de Chimie de Strasbourg
Photographes : Laurent Weber - Pascal Disdier
In vivo imaging platform of Strasbourg-Campus
The "in vivo imaging" team focuses ono the technological development of instrumentation for medical imaging, the development of medical images processing and analysis , and is involved in preclinical and clinical imaging research programs.
The platform benefits from the IbiSA certification.
Integrative Chemistry Biology platform - Drug Discovery Center
The Integrative Chemistry-Biology platform can implement tailored screening methods according to the target of interest (cells, proteins, nucleic acids, ...) and run high throughput screening campaigns using proprietary or clients’ libraries, in ISO 9001 compliant conditions.
Imaging Center of the IGBMC
The imaging platform of the IGBMC in Strasbourg offers a variety of electronic, optical and confocal microscopy tools as well as image and analysis of performed by experienced engineers from various disciplines (biology, physics, computing, opto-mechanical engineering).
The platform has a wealth of experience in the development of innovative solutions to a broad range of problems in the domain of cellular and tissue imaging and they can help in the conception and elaboration of research projects requiring state of the art imaging technologies. The platform can also provide both advice and equipments for the preparation, treatment and analysis of the samples is open to external laboratories, national and international levels
Learn more
Biomechanics platform
The platform is specialized in the biomechanics of shocks applied to the system head - neck - chest.
This multidisciplinary team of scientists and clinicians is involved in many national and international industrial projects in Health (diagnosis, telesurgery, forensics), security, protection and comfort are the areas of direct applications.
Platform research & clinical pre-clinical - xenografts and pediatric brain tumors
The platform was primarily focused on the development of xenograft models of human malignant gliomas but it has expanded its activities to the head and neck cancers, breast and colon carcinomas. The morphological and functional features of the models are regularly monitored using standard histology, immunohistochemistry, genotyping, phenotyping (proliferation and survival), microvascular density and expression of therapeutic targets. Several models are used for preclinical efficacy evaluation of anticancer therapies (chemotherapy, targeted therapies alone or in combination with radiation).
The platform has a national, and international scope.
Alsace will soon be the site of a campus dedicated entirely to medical technologies (Medtech). These facilities will include specific medtech platforms and a University Hospital institute (UHI) for image-guided minimally invasive surgery (MIS).
This institute is destined to become an internationally renowned site for minimally invasive surgery using medical imaging.
Overseen by the IRCAD (Research Institute Against Digestive Cancers), the UHI will offer patients optimal quality care,
while developing innovative equipment and training surgeons in the latest MIS techniques.
Operations to begin in 2013
Download the UHI press release (only available in French)
![]() |
![]() |
|
| © Ircad | © Nogha Consulting |
Specialized technological platforms dedicated to medtech
Platforms are being developed to accomodate the entire range of medtech activities, from prototyping to pre-industrialisation. Researchers will be able to quickly develop prototypes in order to optimize project development, making innovations' benefits accessible to patients in less time.
Project currently underway
Accomodation for Medtech companies
The Medtec campus will offer a wide range of conveniently located accomodations adapted to all activities related to medical technologies (design, production, service).
|
Thanks to the EASE Institute, it's possible to train your future employees in pharmaceutical proceses using a real industrial cleanroom setting. |
|
|
The training centre is based on the "factory-classroom" concept and recreates |
|

The "Hôtel des Plateformes" will offer more than 10,700 sq ft of adapted infrastructures to accomodate technological platforms developed by public researchers looking to reorient their activities towards the industrial sector.
These facilities will make it possible to respond to future challenges in the field of biology by offering a full range of expertise and high level services for the entire value chain, from discovery to development of medicines.
Operations to begin 2013
The unique facilities planned in the BIOMAX project will include France's largest biobank, a bio-clinical database, and analytical platforms. By providing access to a vast collection of perfect samples of the most common complex pathogens, the future Centre for Biological Investigations will be a cutting edge tool to serve clinical research and the pharmaceutical and biotech industries.
Project under consideration


Homepage | Site map | Map | Legal information
© Alsace BioValley, 9 bld Gonthier d'Andernach, 67400 Illkirch, France
Tel +33 (0) 3 90 40 30 00 l admin@alsace-biovalley.com | Conception 2exVia with MasterEdit©